These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 16689555)

  • 1. Under-reporting of adverse drug reactions : a systematic review.
    Hazell L; Shakir SA
    Drug Saf; 2006; 29(5):385-96. PubMed ID: 16689555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal.
    Ribeiro-Vaz I; Santos C; da Costa-Pereira A; Cruz-Correia R
    Drug Saf; 2012 May; 35(5):387-94. PubMed ID: 22468615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.
    Inch J; Watson MC; Anakwe-Umeh S
    Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
    Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
    Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
    Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
    Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK.
    de Vries ST; Denig P; Andrić A; Dimov Di Giusti M; Ptaszynska-Neophytou A; Härmark L; Mol PGM;
    Drug Saf; 2021 Oct; 44(10):1073-1083. PubMed ID: 34368940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.
    Wang N; Chen Y; Ren B; Xiang Y; Zhao N; Zhan X; Feng B
    BMC Health Serv Res; 2022 Mar; 22(1):318. PubMed ID: 35260158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.
    McLernon DJ; Bond CM; Hannaford PC; Watson MC; Lee AJ; Hazell L; Avery A;
    Drug Saf; 2010 Sep; 33(9):775-88. PubMed ID: 20701410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
    Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
    Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of primary care prescribing rates for new drugs on spontaneous reporting of adverse drug reactions.
    Clark RC; Maxwell SR; Kerr S; Cuthbert M; Buchanan D; Steinke D; Webb DJ; Bateman ND
    Drug Saf; 2007; 30(4):357-66. PubMed ID: 17408312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalisations Related to Adverse Drug Reactions in Switzerland in 2012-2019: Characteristics, In-Hospital Mortality, and Spontaneous Reporting Rate.
    Beeler PE; Stammschulte T; Dressel H
    Drug Saf; 2023 Aug; 46(8):753-763. PubMed ID: 37335465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register.
    Wallerstedt SM; Brunlöf G; Sundström A
    Drug Saf; 2011 Aug; 34(8):669-82. PubMed ID: 21751827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain.
    Pedrós C; Vallano A; Cereza G; Mendoza-Aran G; Agustí A; Aguilera C; Danés I; Vidal X; Arnau JM
    Drug Saf; 2009; 32(1):77-83. PubMed ID: 19132807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis.
    Ribeiro-Vaz I; Silva AM; Costa Santos C; Cruz-Correia R
    BMC Med Inform Decis Mak; 2016 Mar; 16():27. PubMed ID: 26926375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
    Hariraj V; Aziz Z
    Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
    Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
    Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Three Different Data Sources of Adverse Drug Reactions Using Adverse Drug Reaction Data of Fluorouracil for Gastric Cancer as an Example.
    Niu R; Chen Y; Xiang Y; Liu Y; Guo J; Feng B
    Biol Pharm Bull; 2020; 43(10):1476-1480. PubMed ID: 32999157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.